Staar Surgical Co. (NASDAQ:STAA) was up 3.6% during mid-day trading on Friday . The company traded as high as $8.69 and last traded at $8.56, with a volume of 64,736 shares trading hands. The stock had previously closed at $8.26.

A number of equities research analysts have issued reports on STAA shares. Zacks Investment Research upgraded Staar Surgical from a “hold” rating to a “buy” rating and set a $9.50 price objective on the stock in a research report on Saturday, August 6th. Benchmark Co. raised Staar Surgical from a “hold” rating to a “buy” rating and set a $6.00 target price on the stock in a research note on Wednesday, May 18th. Stephens cut Staar Surgical from an “overweight” rating to an “equal weight” rating in a research note on Thursday, May 12th. Canaccord Genuity reaffirmed a “hold” rating and set a $7.00 target price on shares of Staar Surgical in a research note on Thursday, May 12th. Finally, William Blair reaffirmed a “market perform” rating on shares of Staar Surgical in a research note on Thursday, August 4th. Four investment analysts have rated the stock with a hold rating and one has given a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus target price of $7.50.

The firm’s market cap is $359.43 million. The company’s 50-day moving average price is $6.64 and its 200-day moving average price is $6.63.

Staar Surgical (NASDAQ:STAA) last posted its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.05) earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.05). The firm earned $21 million during the quarter, compared to analyst estimates of $19.88 million. The company’s revenue for the quarter was up 12.4% on a year-over-year basis. Equities analysts forecast that Staar Surgical Co. will post ($0.31) EPS for the current year.

In related news, Director Richard A. Meier sold 25,000 shares of Staar Surgical stock in a transaction dated Friday, May 20th. The stock was sold at an average price of $5.35, for a total value of $133,750.00. Following the sale, the director now directly owns 27,149 shares in the company, valued at approximately $145,247.15. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, major shareholder Broadwood Partners Lp acquired 336,210 shares of the stock in a transaction that occurred on Monday, May 16th. The stock was purchased at an average price of $5.49 per share, for a total transaction of $1,845,792.90. The disclosure for this purchase can be found here.

An institutional investor recently raised its position in Staar Surgical stock. Mutual of America Capital Management LLC boosted its stake in Staar Surgical Co. (NASDAQ:STAA) by 0.6% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 216,682 shares of the company’s stock after buying an additional 1,299 shares during the period. Mutual of America Capital Management LLC owned about 0.54% of Staar Surgical worth $1,547,000 at the end of the most recent quarter.

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.